Literature DB >> 27540000

Is pruritus an indicator of aquaporin-positive neuromyelitis optica?

Manjunath Netravathi1, Jitender Saini2, Anita Mahadevan3, Bollampalli Hari-Krishna1, Ravi Yadav1, Pramod Kumar Pal1, Parthasarathy Satishchandra1.   

Abstract

BACKGROUND: Recently, pruritus has been recognised as an important association with neuromyelitis optica spectrum disorders (NMOSD).
OBJECTIVE: To determine the clinical and radiological characteristics of patients with NMOSD and pruritus. METHODS AND
RESULTS: Among 57 consecutive patients with NMOSD, 15 (26.3% women) reported pruritus. All had aquaporin-4 (AQP4) antibodies. The mean age was 34.5 ± 9.1 years, age at onset was 31.3 ± 11.0 years and the duration of illness was 3.9 ± 3.1 years. Pruritus preceded the neurological disturbances in all the patients. Predominant patients experienced pruritus in the cervical dermatome (66.7%) followed by cervicothoracic region (13.3%), trigeminal nerve (13.3%) and lumbar region (6.7%). Lesions extending from cervicomedullary junction up to the thoracic segment was the most common site of affection (40%) followed by cervicothoracic (26.7%), cervicomedullary junction to cervical cord (13.3%), cervical cord (6.7%) and thoracic segment (6.7%).
CONCLUSION: This report is one of the largest series reporting the close association of pruritus with onset of neurological symptoms in NMOSD. It highlights the importance of recognising this rare symptom which may help in making a correct diagnosis in a patient with suspected demyelinating disorder. In a patient with NMOSD, early treatment with immunomodulation during pruritus may prevent or minimise occurrence of neurological dysfunction.

Entities:  

Keywords:  NMO; NMOSD; itch; neuromyelitis optica; pruritus

Mesh:

Substances:

Year:  2016        PMID: 27540000     DOI: 10.1177/1352458516665497

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

Review 1.  [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].

Authors:  Orhan Aktas; Tania Kümpfel
Journal:  Nervenarzt       Date:  2021-03-16       Impact factor: 1.214

2.  Isolated Occipital Neuralgia as a Relapse of Neuromyelitis Optica.

Authors:  Andrew Martin; Maria C Garcia
Journal:  Neurol Clin Pract       Date:  2021-12

Review 3.  Itch and neuropathic itch.

Authors:  Junichi Hachisuka; Michael C Chiang; Sarah E Ross
Journal:  Pain       Date:  2018-03       Impact factor: 6.961

4.  Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome.

Authors:  Shripad S Pujari; Rahul V Kulkarni; Dattatraya B Nadgir; Pawan K Ojha; Shashank Nagendra; Vikram Aglave; Rashmi D Nadgir; Hemant Sant; Nilesh Palasdeokar; Satish Nirhale; Sunil Bandishti
Journal:  Ann Indian Acad Neurol       Date:  2020-03-03       Impact factor: 1.383

Review 5.  Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.

Authors:  Andrea Salazar-Camelo; Naveen George; Hesham Abboud; Sarah M Planchon; Marcelo Matiello; Maureen A Mealy; Andrew Goodman
Journal:  J Neurol       Date:  2021-09-05       Impact factor: 4.849

Review 6.  Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

Authors:  Jinming Han; Meng-Ge Yang; Jie Zhu; Tao Jin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-20       Impact factor: 2.570

Review 7.  Neuropathic Itch.

Authors:  James Meixiong; Xinzhong Dong; Hao-Jui Weng
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.